trending Market Intelligence /marketintelligence/en/news-insights/trending/-szo_shmr9rYrmdeq4BUhw2 content esgSubNav
In This List

Viveve Medical settles patent dispute with ThermiAesthetics

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Viveve Medical settles patent dispute with ThermiAesthetics

Viveve Medical Inc. reached a settlement to resolve a patent dispute against ThermiAesthetics LLC, ThermiGen LLC and Red Alinsod in the U.S. District Court for the Eastern District of Texas.

The lawsuit, filed in October 2016, alleges that ThermiAesthetics and its affiliates infringed on the company's patented technology held under U.S. patent No. 8,961,511 and named "Vaginal Remodeling Device and Methods."

Under the settlement, Viveve Medical will receive a monetary payment and on-going royalty. The parties also reached mutual agreements regarding certain intellectual properties.

Englewood, Colo.-based Viveve Medical develops and sells medical devices for treating post-partum conditions.

ThermiAesthetics is a unit of Almirall SA.